Jan 27, 2026, 7:40 AM EST - 1 hour ago
In the last six months Pfizer's stock (NYSE: PFE) has underperformed Merck (NYSE: MRK) and Johnson & Johnson (NYSE: JNJ) primarily due to waning demand for its COVID-19 products, a significant upcomin...
PFE
META
DBP
GLD
GLDM
IAU
OUNZ